Latex and Occupational Allergy Global Market Report 2026

The latex and occupational allergy market size has grown strongly in recent years. It will grow from $1.19 billion in 2025 to $1.28 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rising prevalence of occupational allergies, increased use of latex gloves in healthcare settings, growing regulatory focus on worker safety, expansion of hospital and laboratory infrastructure, increasing reporting of latex-induced anaphylaxis cases.

The latex and occupational allergy market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing demand for latex-free medical supplies, increasing investment in allergy diagnostic technologies, rising workplace health surveillance programs, expansion of industrial safety compliance standards, increasing awareness campaigns on occupational allergies. Major trends in the forecast period include increasing adoption of latex-free product alternatives, rising implementation of occupational health screening programs, growing awareness of workplace allergen exposure risks, expansion of rapid latex-specific IgE diagnostic testing, increasing emphasis on preventive workplace safety policies.

The rising number of surgical procedures is anticipated to drive the growth of the latex and occupational allergy market in the coming years. Surgical procedures refer to medically conducted operations involving incisions, manipulations, or removal of tissues to diagnose, treat, or repair injuries, diseases, or deformities. The increase in surgical procedures is primarily attributed to the growing prevalence of chronic diseases, an aging population, and advancements in medical technology that enable a greater number of surgeries to be performed more safely and effectively. The growing volume of surgical procedures is increasing latex exposure among both healthcare professionals and patients, thereby strengthening the demand for effective solutions within the Latex and Occupational Allergy domain. For instance, according to the 2024 annual report by Intuitive Surgical Inc., a US-based medical device company, approximately 2,683,000 surgical procedures were performed using da Vinci surgical systems, compared to about 2,286,000 procedures in 2023 and 1,875,000 procedures in 2022, indicating consistent year-over-year growth in utilization. Therefore, the rising number of surgical procedures is driving the growth of the latex and occupational allergy market.

Leading companies operating in the latex and occupational allergy market are focusing on developing innovative solutions, such as synthetic disposable latex gloves, to provide latex-free, allergy-safe alternatives with high performance and durability. Synthetic disposable latex gloves are single-use gloves made from a synthetic material that replicates natural latex’s elasticity and tactile feel but contains no natural latex proteins, thereby minimizing allergy risks. For example, in April 2025, Intco Medical Technology Co. Ltd., a China-based manufacturing company, introduced the Synte Synthetic Disposable Latex Gloves, highlighting a material composition free from natural latex proteins and traditional accelerators, adherence with EN455, EN374, food and drug administration, european conformity standards, and enhanced supply chain stability by removing dependence on natural rubber plantations. These gloves offer enhanced comfort, strong protective performance, and environmental advantages, addressing the needs of professionals who require dependable, allergy-safe hand protection across various applications.

The growing healthcare workforce is expected to drive the growth of the latex and occupational allergy market in the coming years. The healthcare workforce includes all individuals involved in activities whose primary objective is to improve health, including physicians, nurses, allied health professionals, technicians, support personnel, and healthcare administrators. The growth of the healthcare workforce is driven by the increasing prevalence of diseases, which raises the demand for healthcare services and requires more professionals to deliver timely and effective medical care. The expansion of the healthcare workforce increases the number of individuals at risk of latex sensitivity by elevating the number of professionals regularly exposed to latex gloves and medical products. Continuous and repeated exposure to latex materials increases the likelihood of allergic reactions, resulting in a higher incidence of occupational latex sensitivity. For instance, in August 2025, according to the U.S. Bureau of Labor Statistics, a US-based federal agency, the number of registered nurses (SOC 29-1141) rose from 3,391,000 in 2024 to 3,557,100 in 2034, representing an increase of 166,100 jobs and steady growth in the profession. Therefore, the growing healthcare workforce is driving the growth of the latex and occupational allergy market.

Major companies operating in the latex and occupational allergy market are Thermo Fisher Scientific Incorporated, Honeywell International Incorporated, 3M Company, Siemens Healthineers Aktiengesellschaft, Medline Industries Inc., Quest Diagnostics Inc., Eurofins Scientific SE, EUROIMMUN Medizinische Labordiagnostika Aktiengesellschaft, Bio-Rad Laboratories Inc., Ansell Limited, ALK‑Abelló A/S, Top Glove Corporation Berhad, Hartalega Holdings Berhad, Kossan Rubber Industries Berhad, R-Biopharm Aktiengesellschaft, HYCOR Biomedical Inc., AESKU.GROUP GmbH And Co. KG, RFB Latex Limited, TG Medical Sdn Bhd, SHIELD Scientific Limited.

North America was the largest region in the latex and occupational allergy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the latex and occupational allergy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the latex and occupational allergy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The latex and occupational allergy market consists of revenues earned by entities by providing services such as occupational health screening programs, workplace exposure risk assessments, allergy management and desensitization therapy, employee health surveillance, environmental monitoring, and consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The latex and occupational allergy market also includes sales of hypoallergenic personal protective equipment (PPE), diagnostic test kits for latex-specific IgE detection, allergen-proof workplace furnishings, protective clothing and barrier creams, respiratory protective masks, allergen detection strips, corticosteroids, and allergen immunotherapy products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Latex and occupational allergy refer to allergic reactions that develop in workers who are exposed to natural rubber latex products within the workplace environment. It is frequently observed among healthcare workers, laboratory personnel, dental professionals, and individuals employed in manufacturing settings where latex gloves or latex-based equipment are regularly utilized. The allergy is caused by proteins present in natural rubber latex and can result in symptoms ranging from skin irritation and contact dermatitis to respiratory complications and, in severe instances, anaphylaxis.

The main product types of latex and occupational allergy include latex-specific immunoglobulin E testing, patch testing systems, latex-free product alternatives, occupational health screening programs, and clinical management solutions. Latex-specific immunoglobulin E testing detects and measures antibodies in patients that indicate sensitization to latex, thereby supporting early identification and effective management of allergic reactions. They are used with treatment types including epinephrine injections for emergency management of severe reactions, antihistamines and other allergy medications, and avoidance strategies through the substitution of latex-free materials. They are applied for reaction or allergy types such as allergic contact dermatitis, which is type four hypersensitivity, immediate hypersensitivity, which includes type one reactions such as anaphylaxis, and other mild to moderate reactions. The various applications involved include healthcare facilities, industrial manufacturing, food service operations, educational institutions, and other occupational environments, and they are used by several end users such as hospitals and clinics, occupational health centers, diagnostic laboratories, government and regulatory agencies, and industrial laboratories and workplaces.

Tariffs on imported natural rubber, latex gloves, and diagnostic testing components have impacted the latex and occupational allergy market by increasing procurement costs for healthcare facilities and industrial workplaces. Regions heavily dependent on latex imports, such as North America and Europe sourcing from Asia-Pacific manufacturing hubs, are particularly affected. Latex-free product alternatives and diagnostic testing kits face pricing pressures due to higher raw material and equipment costs. However, tariffs are encouraging domestic production of latex-free gloves and diagnostic systems, supporting local manufacturing growth and supply chain diversification.

The latex and occupational allergy market research report is one of a series of new reports that provides latex and occupational allergy market statistics, including latex and occupational allergy industry global market size, regional shares, competitors with a latex and occupational allergy market share, detailed latex and occupational allergy market segments, market trends and opportunities, and any further data you may need to thrive in the latex and occupational allergy industry. This latex and occupational allergy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.